Peer Review History
| Original SubmissionMarch 12, 2020 |
|---|
|
PONE-D-20-07225 Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis PLOS ONE Dear Dr. BASNET, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by Jul 10 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE Other section-by-section comments Abstract
Background
Methods and materials
Results
Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Please amend the manuscript submission data (via Edit Submission) to include authors Ali Asghar Mirjat, Falak Zeb and Wiwik Indayati. 4. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1) Innovation perspective the research is not very significant for the researchers globally. Most of the innovations are already available in the literature. As far my knowledge many studies already published these kinds of results. For example, Mahalle et. al. (2016): Association of dietary factors with severity of coronary artery disease. Authors in the manuscript (line no. 257) state “Finally, we found a consistent result with other published studies.” 2) The primary outcome of any case-control study is mainly based on the quality data. If the data is not good quality data then the observations on these data don’t confirm any firm statement. Based on interview questionnaire and the response of the person don’t strongly establish the dietary quantity and quality. If the diet would be provided by any good supply source who would maintain the quantity and quality of the food consumed by the patients, then, the data quality would be much better. 3) There is no external validation of the results. It majorly focused on Nepalese dataset but the research title is generic. External validation (dataset collecting from near countries such as India, Bhutan, Bangladesh) is required for the title otherwise title need to be changed to focus on Nepalese population perspective. 4) The cohort is has been taken from one hospital and therefore, the results may be biased until the data has been taken in standard published process. At least 2 cohorts’ data is required for this study as it is based on face to face interview questions. 5) When we apply model’s then its strength needs to be checked by providing some metrics, such as, model’s stability by providing ROC curve, sensitivity, specificity, accuracy, f-score etc. These are clearly missing here. 6) There are several standard algorithms compared to Random Forest (RF) regression are available. This study chose RF without giving proper justification. 7) Case: control is used 1:1 which is pretty rare in real scenarios. This study has lacks in producing right case and control samples. For example, it doesn’t tell how many patients have participated in the study and how some of them have been excluded from the study with proper logic. By using only Angiography (<70% stenosis) is not enough. 8) In the discussion, some of the statements are contradict with the previous studies. But most of the cases, their rationalities are not explained clearly. 9) Discussion section is not well organized to understand the study as stated in the title. 10) No justification has been given on selecting confounding variables for adjustment. 11) For selecting confounding variables from one result to the next, there are several techniques like forward elimination, backward elimination could be used. 12) There are many statements stated without giving proper references, e.g., line no. 27, 29, 44, etc. and so on. 13) The full questionnaire and data are not exposed to assess the results. 14) Source code of the models and data are available to reproduce the results. 15) Some silly inconsistencies, like, line 144 states p<0.1. Reviewer #2: Review Manuscript Number: PONE-D-20-07225 Manuscript Title: Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis Summary of study This is a retrospective case-control study examining the difference in calorie consumption and intake of 18 nutrients between those with established coronary artery disease (CAD) (n=306) versus a control (n=306). The purpose of the study is to establish associations between the consumption of specific nutrients and CAD in the Nepalese population; associations that the authors believe ought to inform future RCTs/prospective cohort studies and future health policy. It examined a total of 612 patients from the Shahid Gangalal National Heart Centre, Nepal with case-control matched via age and gender. Patients were recruited to the study following admission to the hospital due to a suspected coronary problem (recent suspected myocardial infarction, an exercise induced positive stress test result, or who elected to have an angiography). Patients were assigned to the ‘case’ group if they showed evidence of severe stenosis (>70%). Control subjects were patients who upon arrival were found to have ‘normal’ angiographic results (authors should specify exactly what this means – the flow chart in Fig 1 gives the impression of 0% stenosis) or who were found to have no ECG abnormalities following an exercise stress test. According to the authors, those with intermediate stenosis (<70% obstruction) were excluded from the study, presumably any patient with evidence of stenosis ranging from 1–69%. Data on nutrient consumption over the previous 12-months for each participant was derived from an EPIC food frequency questionnaire. Authors calculated average daily calorie consumption and selected 18 nutrients for analysis – total fat, total carbohydrate, total protein, fibre, calcium, phosphorous, iron, zinc, thiamine, riboflavin, niacin, Vitamin C, β-Carotene, Vitamin A, polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFA), saturated fatty acids (SFA), and cholesterol. Data on known risk factors (diabetes; dyslipidaemia; hypertension; obesity based on BMI; obesity based on central obesity via waist–hip ratio), and data on behaviours believed to be associated with CAD (alcohol consumption; smoking status; and physical activity level) were also recorded for each patient. Using conditional multivariable logistic regression, authors report two statistically significant positive associations after controlling for known risk-factors (model-2): (i) a positive relationship with total fat intake (OR 1.13, 95% CI 1.05–1.21, P≤0.001); (ii) a positive relationship with dietary cholesterol intake (OR 1.06, 95% CI 1–1.12, P=0.02) – note, however, the inclusion of 1 in the confidence interval. The study also found statistically significant differences (inverse associations) between those with CAD and those without in terms of intakes of: (i) total carbohydrate intake (OR 0.93, 95% CI 0.86–0.99, P=0.04); (ii) calcium intake (OR 0.96, 95% CI 0.94–0.99, P=0.003); (iii) zinc intake (OR 0.88, 95% CI 0.79–0.98, P=0.02); (iv) niacin intake (OR 0.8, 95% CI 0.7–0.91, P≤0.001); (v) β-Carotene intake (OR 0.93; 95% CI 0.9–0.97, P=0.001). Following this, the authors use a random forest regression to adjust for collinearity between the variables, which the authors believe allow them to discern the “five topmost important nutrients…linked with CAD: β-Carotene, fat, cholesterol, vitamin C, and fibre intakes”. However, the authors need to provide substantially more detail in the description of results and methodology used for this than is reported here. As it is, I’m not entirely sure what to make of these results. They then proceed to offer a superficial comparison of their findings with the existing literature. This requires extensive revision, however, and the authors need to ensure they avoid committing citation bias here in regards to some of their claims. To do this, they need to show a greater understanding of the conflicting results of large RCTs, prospective cohort studies, and recent meta-analyses. Fortunately, for each of the nutrients examined here, there is an extensive literature on their relationship with CAD/CVD – so the authors really need to engage with this literature. The authors conclude by claiming: “We conclude that dietary β-Carotene, total fat and oil, cholesterol, vitamin C, and fiber in the Nepalese population”. However, I believe, the following points must be addressed before this study can be published: 1. Ethics Before publication, the authors need to include more details about ethical approval. PLOS ONE’s policy on this is as follows: "Human Subject Research (involving human participants and/or tissue) - Give the name of the institutional review board or ethics committee that approved the study - Include the approval number and/or a statement indicating approval of this research - Indicate the form of consent obtained (written/oral) or the reason that consent was not obtained (e.g. the data were analysed anonymously))" The authors state that this study was approved by the Nepal Health Research Council (NHRC). Is the value given here (308/2017-18) the study registration code? Is this associated with certification of ethical clearance by the NHRC ethics committee? Could the authors please attach the appropriate ethical approval documentation as a supplementary file; a letter from the NHRC stating this clearance was provided will suffice. As the authors state that they have received written informed consent by every study participant, could the authors also go into some detail about whether those participants were informed their data (anonymised) would be available open access? 2. Data availability The authors must supply all data associated with their analyses. The authors have claimed all relevant data are supplied in the paper or supplementary files, but this is inaccurate. The results of this paper depend on the analysis of distribution data, and this is necessary for replication. PLOS ONE’s policy states – “PLOS journals require authors to make all data necessary to replicate their study’s findings publicly available without restriction at the time of publication”. Accordingly, the relevant data for every study participant on which this papers analysis depends must either be included as supplementary files or stored in an online data repository after patient data has been appropriately anonymised. These data could be provided in spreadsheets – for the 612 patients, this involves providing all data on control/case group membership, age, weight, gender, dyslipidaemia, hypertension, obesity, smoking, alcohol consumption, physical activity, calorie consumption, and all data regarding intake of the 18 examined nutrients. Indeed, in light of the following problems, it is the data collected by the authors here is probably the most important aspect of the study. 3. Problems concerning data analysis Multiple comparisons: One major problem is accounting for multiple comparisons in this study. For example, Table 2 lists 19 variables (18 nutrients and total calorie consumption) each of which has been compared with a Wilcoxon rank-sum test – so the quoted significance levels at the very least need to be adjusted for the fact that 19 comparisons have been made. The same issue recurs throughout the analysis. The authors should seek to resolve this issue via appropriate statistical methods. I would also recommend that this study is referred to a statistical editor upon these revisions to ensure that this issue has been appropriately resolved. Multicollinearity: Apart from the problem of multiple comparisons here there is also the problem that the data are not fully independent (multicollinearity) – specific micronutrients tend to be associated with other particular nutrients in different food types. Accordingly, it is important not to over interpret associations unless these issues are rigorously excluded. Accordingly, the authors should reflect more on this issue and adjust their methods/interpretations in light of this. One option here would be to extend their discussion of their random forest regression. Indeed, the paper would benefit from extending and deepening the description and results of this analysis, providing results on correlations between nutrient intakes and variance inflation factor. Again, I believe a statistical editor should be consulted. Other data analysis issues: In Table 1, the authors claim that the median age of authors is statistically significantly different between the case and control groups. The authors report the median age, interquartile range, and P-value as: Case: 58 (50–65) | Control: 58 (50–65) | P=0.001 Not only is the median age the same, but so too are the interquartile ranges. Yet, despite this, the age difference is apparently statistically significant? The authors seem to interpret this result as meaningful: “Because the age was matched in five year intervals in the study, the median age was 58 years, which was the same in both case and control groups, respectively, and still showing strong association (P=0.001).” The authors claim that age was matched in 5-year intervals, but are we then to interpret these results as suggesting that there is actually a significant difference in age between case-control matched pairs? As CAD is strongly associated with age in previous research, this is important to clarify. To do this, the authors need to report the age distribution data for both groups as a supplementary file. For the analysis in Table 2, the authors claim “as most of the study data were not normally distributed, median and interquartile range of nutrients are presented”. The authors should, therefore, include in their supplementary material the actual data underpinning their analysis. At the very least, they must include the mean, range, and SD for each nutrient, so the reader can understand exactly what the distribution of these data actually are. Indeed, the data provided in the paper is insufficient to replicate the necessary results reported, despite the authors declaration. Statistical rhetoric: The authors highlight a “highly significant” finding (p.9), this language is inappropriate and should be replaced. A result is simply either significant or non-significant and this is determined by whatever threshold of significance the authors deem necessary. 4. Problems of variable selection and measurement Nutrient selection: The authors select 18 nutrients to examine here, but why these specific nutrients are analysed is not adequately justified. Accordingly, the authors should make clearer why these items were selected for analysis. In the supplementary file, a list of common foods consumed is provided. This raises further questions about why the authors chose only to analyse the variables they selected in this paper because other variables appear possible to derive from their data. For example, I see no reason why the amount of sugars in the diet couldn’t be calculated from the listed food items, so why isn’t this examined in the paper? Similarly, their decision to use total carbohydrate intake as a variable without breaking this down into refined and complex carbohydrates appears strange and problematic, particular because the authors acknowledge in the paper that there are important differences between these. Why then didn’t the authors calculate these? In its current state, this Table of food items is both uninformative and misleading. It also raises further questions about how nutrient intakes were measured. Patients were asked about milk consumption, but the milk category does not clarify whether respondents were asked specifically about the amount of full, semi, or skimmed milk consumed, which would be necessary to understand fat content and fatty acid profiles, or whether this was a single category. Further questions about how the quantities of PUFA, MUFA, and SFA were calculated arise in regards to several of the vague categories, such as “vegetable oils”. Accordingly, the authors should include the specific dietary survey actually provided to patients. Furthermore, supplying the average amount of each food consumed by cases and controls for each item would shed more light on dietary habits. As recent research suggests different whole foods might have different effects on lipid profiles and thereby atherosclerosis, these data are important to report. At the very least the authors need to make available the intakes of each nutrient examined in this study per patient. Other questions that arise are why were PUFA here considered as a single group and not split further into Omega-3 and Omega-6 variants? Why was the intake of trans-fats not measured? Thus, the authors need to revise the manuscript to give the reader a clearer understanding of the theoretical justification for the selection of the variables. As there is a voluminous literature on the relationship between diet and atherosclerosis/CHD/CVD extending back to the early 20th century, there is a wonderfully rich literature to draw from. Self-reported nutritional data: As all the nutritional data are all self-reported, the authors should include a clearly discussion in regards to their reliability given the known problems with this kind of data. I suspect there is a problem here. From Table 2, it appears that total daily nutritional intake was virtually the same in the two groups – despite the significantly higher incidence of obesity in the control group. 5. Referencing In-text references in this paper appear occasionally only loosely related to the claims they are purported to be associated with. For example, reference number 2 is inserted after the following sentence: “In Nepal, 30% of total death was related to cardiovascular disease (2).” Yet, reference 2 is a paper by Rankinen et al. (2015), and nowhere in this paper is this claim made. Another reference chosen at random, reference 20, is used to support the authors claim that: “Besides cholesterol is also an independent risk factor of CAD according to the lipid theory” The paper referenced nowhere discussed dietary cholesterol. It is a paper examining, as the title suggests, the “Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension”. The only mention of cholesterol in this paper is HDL-C and LDL-C – that is, cholesterol bound in particular classes of lipoproteins carried in the blood. If the authors make the rest of the revisions outlined, I will examine each of the references of this paper. So my recommendation would be to go through each reference and ensure it is relevant to the claim being made. As discussed, the authors also need to ensure they have adequately represented the state of research in relation to their claims. If the article is resubmitted, I’ll check each 6. Flawed study design However, there is one problem that may undermine the point of revising this manuscript. The authors have a case-matched control group – but the control group are not healthy individuals, but patients with other health conditions and cardiovascular symptoms. This is clearly evident by the way the authors chose to enrol patients – all patients were being examined because of suspected coronary problems. This makes it impossible to talk of differences between these groups in terms of risk factors. For example, looking at Table 1, the ‘control’ group has a significantly higher incidence of obesity and central obesity – but it would be obviously wrong to conclude that obesity and central obesity are protective against cardiovascular disease. Here we’re seeing a stratification of phenotypic characteristics between two different patient groups, and from this we can’t conclude anything at all about risk. This might also explain the extremely strange finding that the number of hypertensives was roughly the same in both the control and case groups - Control: 143 hypertensives (~46.7%) | Case: 142 hypertensives (~46.4%). As hypertension is one of the key known risk factors in the development of CAD/CVD and extensively supported in the literature, this finding requires a lot more reflection. Why were hypertensives so common in the control group? This control group had apparently no evidence of stenosis – so this seems to be quite an important avenue to explore what went on here. Accordingly, this design is inappropriate for the authors stated intention: “The present case-control study was designed to determine the association of dietary nutrients with CAD in the Nepalese population”. If this study is to be published, the authors need to somehow explain why this control group can be considered representative of a broader population. Later in the paper the authors do highlight the results may have been biased due to “the selection of the control group from the outdoor patients from the same hospital where more hypertensive patients come for their heart check-up”, but this seems to critically undermine the entire results of this study. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-07225R1 Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis PLOS ONE Dear Dr. Basnet, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by Nov 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: First, I must thank the authors for their careful response to the previous round of reviews. Indeed, the changes the authors have made to the manuscript represent an important improvement, particularly the added details related to methodology and the supplementary data and script. However, there are still issues to be addressed: 1. Study design and generalisability My primary concern remains the conclusions that the authors draw from their analysis. Previously, I highlighted: “The authors have a case-matched control group – but the control group are not healthy individuals, but patients with other health conditions and cardiovascular symptoms. This is clearly evident by the way the authors chose to enrol patients – all patients were being examined because of suspected coronary problems. This makes it impossible to talk of differences between these groups in terms of risk factors. If this study is to be published, the authors need to somehow explain why this control group can be considered representative of a broader population. Later in the paper the authors do highlight the results may have been biased due to “the selection of the control group from the outdoor patients from the same hospital where more hypertensive patients come for their heart check-up”, but this seems to critically undermine the entire results of this study.” This remains my position. The authors have not adjusted their conclusions or their interpretation of their study in light of the problems related to their study design. There is no attempt in this study to understand whether the control group is representative of the broader Nepalese population, and there is a major risk of selection bias. This is clearly indicated by the similar number of hypertensive patients in the case and control groups. For example, the major conclusion of this paper remains: “Thus, a dietary intervention approach in CVDs is an effective strategy to reduce the public health burden. We conclude that dietary SFA, vitamin A.R.E., dietary total fat and oil, β-carotene, and cholesterol are topmost five essential dietary nutrients associated with CAD in the Nepalese population.” The findings of this paper cannot be extended to make claims about the relationship between the intake of any dietary nutrient in the wider Nepalese population and their risk of CAD. The findings are at best suggestive of a possible relationship between these nutrients and the development of CAD, but prospective cohort studies and RCTs will need to be performed, as the authors do go on to highlight. Further, it is also clear that the case group here differs drastically from the control group in many important aspects. Compared to the controls, the case group has more than double the number of patients with diabetes, double the number obese (BMI) patients, triple the number of patients suffering from dyslipidaemia, and triple the number who are current smokers. They cases also drink more alcohol and exercise less than the control group. These groups are not comparable – and clearly have very different lifestyles, so it is not clear to me that the authors can draw any conclusions about the respective role of specific nutrients in explaining CAD between the groups. Accordingly, more needs to be done to modify the conclusions of this paper and highlight the limitations of this study before publication. As there are questions over the generalisability of these findings beyond the study population, my recommendation would be to limit all conclusions to describing the findings of this study in relation to this group alone. 2. Unexplained differences in findings reported between the original and revision. The authors must explain why some figures in this revised manuscript compared to the original have changed. Specifically, I refer to Table 2. In the original, for Food energy (kcal) per day, the controls are reported as 2560 (2306, 2791) and the cases 2549 (2256, 2897) kcal. However, in the revised manuscript, the controls now are reported as 2674 (2445, 2909) and the cases 2622 (2373, 2963). Despite this change, none of the other macronutrient values have changed, which cannot be true. Further, I cannot understand how the authors have also changed values for PUFA and SFA intake in this revised version compared to the original – but somehow this has not changed the value for total fat intake? In this original paper, Fat g Control 56 (47, 64) | Case 61 (52, 72) PUFA g Control 18 (11.2, 22.7) | Case 19.6 (11.8, 25.7) SFA g Control 15.8 (10.8, 20)| Case 16.6 (11, 21.6) In the revised manuscript, Total fat/oil g Control 56 (47, 64)| Case 61 (52, 72) PUFA g Control 18.7 (12.5, 23.5) | Case 19.6 (12.4, 25.7) SFA g Control 15.5 (10.6, 19.2) | Case 19 (13.9, 23.6) The authors need to explain why this discrepancy has occurred because it undermines my confidence in the reliability of these data. I am particularly worried about the change in SFA values because the authors now report a significant OR of 1.2 (1.11, 1.31) for SFA intake in the revised manuscript, which was not included in the original. Another major change is the figures concerning vitamin A,E,R intake between these versions: In the original: Vitamin A R.E. Control 739 (578, 885)| Case 657 (535, 790) In the revised: Vitamin A R.E. Control 698 (546, 836)| Case 622 (506, 728) Either there was a major problem with the basic statistical analysis performed for the previous version of this paper, or these data have since been changed. 3. Referencing problems Some references still do not clearly relate to the statements made by the authors. For example, the authors state: "An estimated 7.4 million people died from CAD in 2015, representing 13% of all global deaths. In Nepal, 30% of total death was related to cardiovascular disease [2]". The reference provided for this is “WHO. Cardiovascular diseases fact sheet. WHO. World Health Organization; 2017”. Nowhere in this referenced document are either of these figures provided. 4.Summary My recommendation, despite the improvements to the paper in many areas, remains to reject this paper. Previously, this was based on the flawed study design that, I believed, undermined the generalisability of these results to the broader Nepalese population. However, the unexplained changes to nutrient intakes in this revised version undermined my confidence in this study. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-07225R2 Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis PLOS ONE Dear Dr. Basnet, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Please submit your revised manuscript by Dec 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis PONE-D-20-07225R3 Dear Dr. Basnet, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-07225R3 Dietary nutrients of relative importance associated with coronary artery disease: Public health implication from random forest analysis Dear Dr. Basnet: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Samson Gebremedhin Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .